1. Home
  2. NMTC vs CDLX Comparison

NMTC vs CDLX Comparison

Compare NMTC & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$3.35

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Logo Cardlytics Inc.

CDLX

Cardlytics Inc.

HOLD

Current Price

$5.34

Market Cap

30.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMTC
CDLX
Founded
2009
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
29.2M
30.2M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
NMTC
CDLX
Price
$3.35
$5.34
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
$11.90
$2.25
AVG Volume (30 Days)
25.5K
311.6K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
80.43
50.13
EPS
N/A
N/A
Revenue
$9,097,692.00
$233,273,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$31.90
$8.82
P/E Ratio
N/A
N/A
Revenue Growth
163.47
N/A
52 Week Low
$0.55
$0.55
52 Week High
$5.40
$6.40

Technical Indicators

Market Signals
Indicator
NMTC
CDLX
Relative Strength Index (RSI) 41.27 81.37
Support Level $0.69 $0.83
Resistance Level $4.87 $6.40
Average True Range (ATR) 0.20 0.46
MACD -0.02 0.18
Stochastic Oscillator 36.75 80.59

Price Performance

Historical Comparison
NMTC
CDLX

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

About CDLX Cardlytics Inc.

Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.

Share on Social Networks: